Apelin-13 attenuates doxorubicin-induced myocardial injury via the PI3K/AKT and ERK/MAPK signaling pathways.

Cardiovasc Diagn Ther · 2026 · PMC13345812 · PMID 42428641

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

an increasing trendno p-value reported

The heart rate of the mice in the DOX group showed an increasing trend compared with the controls, and compared with the mice in the DOX group, the heart rate of the mice in the Apelin-13 group showed a decreasing trend.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.